Cargando…

Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease

BACKGROUND: Coronavirus disease 2019 (COVID-19) and inflammatory bowel disease (IBD) are both caused by a disordered immune response and have direct and profound impacts on health care services. In this study, we implemented transcriptomic and single-cell analysis to detect common molecular and cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chengyan, Ma, Zeyu, Nan, Xi, Wang, Wenhui, Zeng, Xianchang, Chen, Jinming, Cai, Zhijian, Wang, Jianli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936160/ https://www.ncbi.nlm.nih.gov/pubmed/36817436 http://dx.doi.org/10.3389/fimmu.2023.1024041

Ejemplares similares

The regulatory role of alternative splicing in inflammatory bowel disease
por: Zhou, Jianli, et al.
Publicado: (2023)

Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation
por: Shen, Yingying, et al.
Publicado: (2022)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence
por: Esposito, Susanna, et al.
Publicado: (2022)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

Exosome-Induced Regulation in Inflammatory Bowel Disease
por: Zhang, Huiting, et al.
Publicado: (2019)

Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease
por: Xu, Alexander M., et al.
Publicado: (2022)

Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease
por: Stercel, Vivien, et al.
Publicado: (2023)

Treatment of Inflammatory Bowel Disease: A Comprehensive Review
por: Cai, Zhaobei, et al.
Publicado: (2021)

Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease
por: Wang, Shu-Ling, et al.
Publicado: (2018)

Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis
por: Xie, Wenhui, et al.
Publicado: (2022)

Interleukin-17 and inflammatory bowel disease: a 2-sample Mendelian randomization study
por: Cai, Yangke, et al.
Publicado: (2023)

Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
por: Otten, Antonius T., et al.
Publicado: (2022)

CXCL13 is elevated in inflammatory bowel disease in mice and humans and is implicated in disease pathogenesis
por: Liu, Ting, et al.
Publicado: (2022)

The role of intestinal immune cells and matrix metalloproteinases in inflammatory bowel disease
por: Mei, Kun, et al.
Publicado: (2023)

Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
por: Che, Zhengping, et al.
Publicado: (2022)

Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases
por: Kühl, Anja A., et al.
Publicado: (2015)

Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis
por: Loddo, Italia, et al.
Publicado: (2015)

Role of Incretin Axis in Inflammatory Bowel Disease
por: Duan, Lihua, et al.
Publicado: (2017)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

NLRP3 Inflammasome and Inflammatory Bowel Disease
por: Zhen, Yu, et al.
Publicado: (2019)

The Role of Dietary Nutrients in Inflammatory Bowel Disease
por: Sugihara, Kohei, et al.
Publicado: (2019)

Application of Zebrafish Models in Inflammatory Bowel Disease
por: Hanyang, Li, et al.
Publicado: (2017)

Inflammatory Bowel Diseases: It's Time for the Adenosine System
por: Antonioli, Luca, et al.
Publicado: (2020)

Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases
por: Wallace, Jonathan W., et al.
Publicado: (2021)

Inflammatory Bowel Disease Therapy: Beyond the Immunome
por: Fiocchi, Claudio, et al.
Publicado: (2022)

Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine
por: Ning, Lijun, et al.
Publicado: (2023)

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
por: Li, Lingfeng, et al.
Publicado: (2022)

The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?
por: Zou, Min, et al.
Publicado: (2021)

The role of amino acid metabolism in inflammatory bowel disease and other inflammatory diseases
por: Zheng, Xiaowen, et al.
Publicado: (2023)

Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment
por: Yan, Dong, et al.
Publicado: (2023)

Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
por: Imam, Tanbeena, et al.
Publicado: (2018)

Transient Receptor Potential Channels and Inflammatory Bowel Disease
por: Chen, Yiding, et al.
Publicado: (2020)

Malassezia in Inflammatory Bowel Disease: Accomplice of Evoking Tumorigenesis
por: Yang, Qiyu, et al.
Publicado: (2022)

A broad cuproptosis landscape in inflammatory bowel disease
por: Chen, Yuan, et al.
Publicado: (2022)

Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease
por: Lee, Hoyul, et al.
Publicado: (2023)

miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease
por: Xiao, Xiangjun, et al.
Publicado: (2022)

Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
por: Wang, Yifei, et al.
Publicado: (2022)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection
por: Conway, Susan R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_utov87gr5gomraancljs2646tn